Top-20-Biopharma nutzt die Veeva Development Cloud, um die Entwicklung von Therapien für derzeit unheilbare Krankheiten zu beschleunigen INGELHEIM, Deutschland und BARCELONA, Spanien, 12. März 2025 /PRNewswire/ — Heute haben Boehringer Ingelheim und Veeva Systems (NYSE: VEEV) den Start…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.